Latest Breaking News On - Bridgewest group portfolio - Page 1 : vimarsana.com

MIAMI and PERTH, Australia, April 26, 2023 /PRNewswire/ Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, establishes LumaCina business unit under Bridgewest Perth Pharma in Perth, Australia. The newly created business leverages the acclaimed team and production facility recently acquired by Bridgewest Group from Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc., plus the addition of newly expanded capabilities, most notably, R & D. LumaCina will commercialize sterile injectable drugs in global markets and is actively expanding its portfolio through increased production under LumaCina branding. "Our recent acquisitions in Australia are a reflection of the importance we place in meeting the growing demand for high quality pharmaceuticals, both regionally, and globally. LumaCina increases our ability to help healthcare professionals readily access quality sterile injectable medicines w

Western australiaNew zealandUnited statesJenny bourbielJon kaferMasood tayebiIan wisenbergLife sciencesPerth pharma pty ltdPfizer incBridgewest group portfolio companyBridgewest groupPfizer perth pty ltdBridgewest perth pharmaPty ltdChief commercial officer